First Time Loading...

Modalis Therapeutics Corp
TSE:4883

Watchlist Manager
Modalis Therapeutics Corp Logo
Modalis Therapeutics Corp
TSE:4883
Watchlist
Price: 77 JPY Market Closed
Updated: Apr 30, 2024

Modalis Therapeutics Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Modalis Therapeutics Corp
Revenue Peer Comparison

Comparables:
2160
4587
4974
J
7774
S
4599

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Modalis Therapeutics Corp
TSE:4883
Revenue
¥0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
Revenue
¥26B
CAGR 3-Years
39%
CAGR 5-Years
39%
CAGR 10-Years
64%
PeptiDream Inc
TSE:4587
Revenue
¥28.7B
CAGR 3-Years
35%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Takara Bio Inc
TSE:4974
Revenue
¥47.7B
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
8%
J
Japan Tissue Engineering Co Ltd
TSE:7774
Revenue
¥2.4B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
11%
S
StemRIM Inc
TSE:4599
Revenue
¥2.4B
CAGR 3-Years
4%
CAGR 5-Years
64%
CAGR 10-Years
N/A

See Also

What is Modalis Therapeutics Corp's Revenue?
Revenue
0 JPY

Based on the financial report for Dec 31, 2023, Modalis Therapeutics Corp's Revenue amounts to 0 JPY.